Table 2.
Association between CRKL expression and clinicopathological factors in 360 patients with primary gastric cancer
| CRKL expression level | ||||
|---|---|---|---|---|
| Factor |
Patient |
Low (n = 272) |
High (n = 88) |
P |
| Age |
|
|
|
|
| Year, mean ± SDa |
62.0 ± 11.2 |
61.7 ± 11.7 |
62.9 ± 11.4 |
0.3936b |
| (range) |
(29–86) |
(29–86) |
(31–85) |
|
| Gender |
|
|
|
|
| Male |
255 |
182 (66.9%) |
73 (83.0%) |
0.0028c |
| Female |
105 |
90 (33.1%) |
15 (17.0%) |
|
| Histological type |
|
|
|
|
| Differentiated |
172 |
118 (43.4%) |
54 (61.4%) |
0.0033c |
| Undifferentiated |
188 |
154 (56.6%) |
34 (38.6%) |
|
| pT stage |
|
|
|
|
| pT1 |
143 |
103 (37.9%) |
40 (45.5%) |
0.2082c |
| pT2-pT4 | 217 | 169 (62.1%) | 48 (54.5%) | |
a SD, standard deviation. bt-test. c Chi-square test.